Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis

OBJECTIVE: We compared the 52-week effectiveness and safety of tofacitinib (TOF) and abatacept (ABT) in patients with RA in a real-world setting and investigated a role of human leucocyte antigens (HLA)-DRB1 shared epitope (SE) in the effectiveness. METHODS: RA patients starting TOF (n = 187) and AB...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Wataru, Harigai, Masayoshi, Amano, Koichi, Hidaka, Toshihiko, Itoh, Kenji, Aoki, Kazutoshi, Nakashima, Masahiro, Nagasawa, Hayato, Komano, Yukiko, Nanki, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667967/
https://www.ncbi.nlm.nih.gov/pubmed/36407801
http://dx.doi.org/10.1093/rap/rkac090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667967/
https://www.ncbi.nlm.nih.gov/pubmed/36407801
http://dx.doi.org/10.1093/rap/rkac090

Ejemplares similares